Your DNA is yours. Your health data is yours. Your body is yours. The Biological Frontier Foundation fights to keep it that way — protecting biological civil liberties in an era of genetic surveillance, data exploitation, and corporate ownership of human biology.
Just as the Electronic Frontier Foundation was founded in 1990 to protect civil liberties in the digital world, the Biological Frontier Foundation exists to defend the rights of individuals over their own biological existence.
We live in an age where your genome can be sequenced for under $200, your biometric data is captured dozens of times daily, and corporations can patent the building blocks of life itself. Yet legal protections for biological data remain fragmented, outdated, and woefully inadequate.
The BFF provides legal defense, policy advocacy, public education, and technological tools to ensure that every person maintains sovereignty over their biological identity.
"The most intimate data about a human being — their DNA, their cells, their biological identity — deserves at least the same protections we demand for our emails and phone calls."— Biological Frontier Foundation, Founding Principles
From forced sterilization to genetic surveillance, the struggle for biological rights has shaped — and been shaped by — some of the most consequential legal battles in history.
The U.S. Supreme Court ruled 8-1 that compulsory sterilization of the "unfit" was constitutional. Justice Oliver Wendell Holmes infamously declared "Three generations of imbeciles are enough." Over 60,000 Americans were forcibly sterilized under laws this decision enabled, and the ruling was cited by Nazi defendants at Nuremberg. The decision has never been explicitly overturned.
Court Case · Bodily AutonomyThe U.S. Public Health Service began a 40-year study on nearly 400 Black men with syphilis in Tuskegee, Alabama. Participants were told they were receiving "special free treatment" but were never given penicillin, even after it became standard treatment. By the study's end in 1972, 28 had died of syphilis, 100 from complications, 40 wives were infected, and 19 children were born with congenital syphilis.
Violation · Informed ConsentThe Supreme Court struck down Oklahoma's Habitual Criminal Sterilization Act, ruling that procreation is "one of the basic civil rights of man." While not explicitly overturning Buck v. Bell, this decision significantly weakened its precedent by establishing strict scrutiny for laws affecting reproductive rights.
Court Case · Reproductive RightsCervical cancer cells were harvested from Henrietta Lacks at Johns Hopkins Hospital without her knowledge or consent. Her "immortal" HeLa cells became one of the most important tools in medicine — contributing to the polio vaccine, cancer research, and over 100,000 scientific publications — while her family received nothing and remained unaware for decades. The case became a catalyst for bioethics reform.
Violation · Cell Line RightsPassed in direct response to the Tuskegee revelations, this act established the requirement for Institutional Review Boards (IRBs) to review all federally funded human subjects research. It created the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, which produced the landmark Belmont Report in 1979.
Legislation · Research EthicsJohn Moore's cancerous spleen cells were developed into a patented cell line worth billions without his knowledge. The California Supreme Court ruled that patients have no property rights over their discarded biological materials, though physicians have a duty to disclose financial interests. This devastating precedent essentially declared that once cells leave your body, they are no longer yours.
Court Case · Cell OwnershipThe Federal Policy for the Protection of Human Subjects was adopted by 15 federal agencies, establishing uniform standards for informed consent, IRB review, and protections for vulnerable populations including pregnant women, prisoners, and children. Revised significantly in 2018 to address modern research methods.
Legislation · Research EthicsThe Health Insurance Portability and Accountability Act established the first national standards for protecting individually identifiable health information. The Privacy Rule (effective 2003) and Security Rule (effective 2005) created a framework for health data protection — though significant gaps remain, particularly for consumer health apps and direct-to-consumer genetic testing companies.
Legislation · Health DataFamilies who donated tissue and funding to Canavan disease research discovered the researcher had secretly patented the gene they helped identify. The court dismissed most claims but upheld unjust enrichment, establishing that research donors don't own their tissue but may have claims when researchers profit from their contributions without disclosure.
Court Case · Genetic ResearchAfter 13 years of advocacy, Congress passed GINA with overwhelming bipartisan support (95-0 in the Senate). The law prohibits genetic discrimination in health insurance and employment but notably fails to cover life insurance, disability insurance, or long-term care — leaving critical gaps. It was a landmark first step but remains incomplete protection.
Legislation · Genetic PrivacyThe DIYbio organization launched, catalyzing a global movement of citizen scientists, biohackers, and community biology labs. Genspace (2010) became the first community bio lab, followed by BioCurious and others. The movement champions democratized access to biotechnology and the right of individuals to study and modify biology outside institutional settings.
Movement · Biological AutonomyIn a unanimous decision, the Supreme Court ruled that naturally occurring DNA segments are products of nature and cannot be patented, invalidating Myriad's patents on the BRCA1 and BRCA2 cancer-risk genes. The decision struck down thirty years of gene patents by the USPTO and opened up genetic testing to competition, dramatically increasing accessibility of cancer screening.
Court Case · Gene PatentsThe Supreme Court ruled 5-4 that collecting DNA from arrestees (not just convicts) is constitutional, likening it to fingerprinting. Justice Scalia's blistering dissent, joined by Ginsburg, Sotomayor, and Kagan, warned this suspicionless biological search was "the most important criminal procedure case this Court has heard in decades" — and a dangerous expansion of state power over biological identity.
Court Case · DNA SurveillanceWhen researchers published the complete HeLa genome without the Lacks family's consent, the resulting outcry led to an unprecedented NIH agreement: scientists must now receive permission from a committee that includes Lacks family members to access the HeLa genome for NIH-funded research, establishing a new model for donor involvement in genetic research governance.
Movement · Genetic PrivacyFounded by Anthony Di Franco, the Open Insulin Project aimed to reverse-engineer insulin production and release open-source protocols, potentially reducing costs by 98%. The project embodies the principle that access to life-saving medicine is a biological right, echoing Frederick Banting's 1923 decision to sell his insulin patent for just $1.
Movement · Access to HealthThe Supreme Court ruled that accessing historical cell phone location data requires a warrant, establishing that individuals retain Fourth Amendment rights in data disclosed to third parties. Legal scholars note this framework has profound implications for biological data: if location data deserves protection, genetic and biometric data — far more intimate — should demand even greater safeguards.
Court Case · Data PrivacyLaw enforcement identified Joseph James DeAngelo by uploading crime scene DNA to GEDmatch, a public genealogy database, and tracing family trees to find him through his relatives' DNA. While the arrest was celebrated, the technique exposed how submitting your DNA also subjects all your biological relatives to potential surveillance — without their knowledge or consent.
Violation · Genetic SurveillancePresident Trump signed the Right to Try Act, allowing terminally ill patients who have exhausted approved treatment options to access investigational drugs that have passed Phase I clinical trials, bypassing the FDA's expanded access process. The law affirmed the principle that patients have a right to make decisions about their own bodies and treatment.
Legislation · Access to TreatmentCalifornia became the first state to directly regulate CRISPR technology, requiring that DIY gene-editing kits carry warnings stating they are "not for self-administration." The law highlighted the tension between individual biological autonomy and public safety, a debate that continues to intensify as gene-editing tools become increasingly accessible and affordable.
Legislation · Gene EditingIllinois's Biometric Information Privacy Act, enacted in 2008, became the most consequential biometric privacy law in the U.S. — the only state law with a private right of action. By 2025, over 107 new BIPA class actions were filed in a single year, with settlements including Clearview AI ($51.75M) and Facebook ($650M). The law inspired biometric privacy legislation in Texas, Washington, and beyond.
Legislation · Biometric PrivacyInvestigations revealed that states were storing newborn blood spot samples for decades — and sharing them with law enforcement and researchers without parental knowledge or consent. New Jersey was sued for retaining samples over 20 years; California stores samples indefinitely with no opt-out. More than a quarter of U.S. states have no policy restricting law enforcement access to these samples.
Violation · Genetic Surveillance23andMe filed for bankruptcy on March 23, 2025, putting the genetic data of over 15 million people at risk of being sold as a corporate asset. The database was ultimately acquired for $305 million by a nonprofit created by 23andMe's own founder. 25 state attorneys general moved to halt the sale, exposing the absence of federal law protecting genetic data held by consumer companies outside of HIPAA's reach.
Violation · Data SovereigntyThe BFF works across six interconnected domains where biological civil liberties are most threatened — and most in need of defense.
Protecting your DNA data from corporate exploitation, government surveillance, and unauthorized research. Your genetic code is the most personal data that exists — it should never be bought, sold, or accessed without your explicit, informed, and revocable consent.
You should own and control your complete health records — every test result, diagnosis, prescription, and clinical note. We fight for true data portability, the right to export, delete, and restrict access to health information across all platforms and providers.
The right to make informed decisions about your own body — including the right to access experimental treatments, to modify your own biology, and to refuse unwanted biological interventions. Your body, your choice, your sovereignty.
From Henrietta Lacks to modern biobanks, the question of who owns your biological materials remains unresolved. We advocate for clear legal frameworks that give individuals ownership and benefit-sharing rights over their cells, tissues, and biological derivatives.
Facial recognition, fingerprint scanning, iris detection, voice prints, gait analysis — biometric surveillance is expanding rapidly. We fight for the right to move through the world without your body being used as a tracking device, and for strong laws like Illinois BIPA nationwide.
The right to experimental treatments, open-source medicine, DIY biology, and community-driven health research. We support initiatives like the Open Insulin Project and the Right to Try Act — because access to the tools of biological understanding should not be gated by wealth or institutional power.
Modeled after the Electronic Frontier Foundation's proven structure, the BFF combines legal firepower, policy expertise, grassroots advocacy, and technological innovation to defend biological rights.
Impact litigation attorneys who take on precedent-setting cases involving genetic privacy, cell line ownership, biometric surveillance, and biological autonomy. Like EFF's legal team, we file amicus briefs, represent individuals, and challenge unconstitutional laws.
Advocates who work with legislators at state and federal levels to draft and advance biological rights legislation — from comprehensive genetic privacy laws to biometric protection statutes and patient access reforms.
Scientists, bioethicists, and legal scholars who produce white papers, threat assessments, and policy recommendations on emerging biological technologies and their civil liberties implications — from AI-driven genomics to synthetic biology.
Community organizers and educators who run public awareness campaigns, know-your-rights workshops, and coalition-building efforts. We empower individuals to understand and exercise their biological rights.
Engineers and developers building open-source tools for encrypted health data storage, genetic data sovereignty platforms, and biometric opt-out technologies — giving people practical tools to protect their biological privacy.
These speculative case studies — set 5 to 15 years from now — illustrate the legal battles ahead. The precedents we set today will determine the outcome.
In 2031, Dr. Elena Reyes — a molecular biologist and carrier of the BRCA1 mutation — watches her sister die of breast cancer after years of prohibitively expensive treatment. Reyes, who had been denied coverage for a preventive gene therapy by her insurer, designs and self-administers a CRISPR-based therapy targeting the BRCA1 mutation in her own somatic cells.
She documents her protocol openly, publishing her methods and results on an open-science platform. Within months, dozens of other BRCA carriers begin following her protocol. The FDA, under pressure from pharmaceutical companies with competing (and far more expensive) gene therapies in their pipelines, charges Reyes with manufacturing and distributing an "unapproved biological product" under the Federal Food, Drug, and Cosmetic Act.
The BFF takes her case, arguing that Reyes has a fundamental right to modify her own biological material — that bodily autonomy necessarily includes the right to alter one's own genome for therapeutic purposes. The prosecution argues that without FDA oversight, self-administered gene therapies pose unacceptable risks to the individual and, potentially, to the gene pool.
A ruling for Reyes could establish a constitutional right to self-directed gene therapy, forcing regulators to distinguish between personal biological modification and commercial drug distribution. A ruling against her could criminalize an entire category of self-care and entrench pharmaceutical gatekeeping over genetic medicine.
In 2035, Amara Okafor discovers that GenomeLink — a consumer genetics company she submitted her saliva sample to in 2027 — sold her anonymized genomic data to HelixPharma Corp. as part of a bulk dataset of 8 million genomes. HelixPharma's AI identified a rare genetic variant in Okafor's genome that conferred natural resistance to a form of liver disease. They used this discovery to develop a blockbuster drug now generating $4 billion annually.
Okafor learns of this when she recognizes her own genetic variant described in HelixPharma's published research. She sues for ownership rights over derivatives of her genetic information, seeking compensation and an injunction requiring her consent for future use. HelixPharma argues the data was anonymized, covered by GenomeLink's Terms of Service, and that the drug is a novel invention, not a copy of her DNA.
The BFF intervenes on Okafor's behalf, arguing that consent obtained through a clickwrap agreement for a consumer genetics service cannot extend to pharmaceutical development worth billions, and that the concept of "anonymization" is a fiction when dealing with genetic data — which is, by definition, personally identifiable.
A ruling for Okafor could establish that genetic data constitutes a form of intellectual property belonging to the individual, creating a new legal framework for benefit-sharing in genomic medicine. It could also invalidate the business model of every consumer genetics company that relies on broad ToS consent for data monetization, reshaping the entire biotech industry.
In 2038, James Washington — a senior software engineer at a Fortune 500 tech company — is informed that the company's new health insurance program, administered by Meridian Health Systems, requires all employees to wear a continuous biometric monitoring device (tracking heart rate, blood oxygen, sleep patterns, stress hormones, and glucose levels) and submit to annual genetic screening. Employees who comply receive a 40% premium reduction; those who refuse pay the full, substantially higher rate.
Washington refuses, citing religious beliefs, privacy concerns, and a family history of genetic conditions he does not wish to disclose. He is not fired outright but is placed on an "alternative benefits track" with significantly reduced health coverage, effectively making his position economically untenable. He resigns and sues under Title II of GINA, the ADA, and a novel biological civil liberties theory.
The BFF files on behalf of Washington, arguing that mandatory biometric surveillance as a condition of employment constitutes compelled biological disclosure — a violation of the fundamental right to biological privacy — and that financial penalties for refusal are constructive compulsion.
A ruling for Washington could establish that biological monitoring cannot be economically compelled, creating a bright-line rule against mandatory biometric surveillance in the workplace. It would force a reckoning with the growing practice of employers using health data as a condition of benefits, and could catalyze a new federal Biological Privacy Act.
The fight for biological civil liberties is just beginning. Here's how you can help build the future of biological rights.
Has your genetic data been shared without consent? Were you discriminated against based on biological information? Have your biometric rights been violated? Report it to the BFF and we'll investigate.
Join our network of attorneys, scientists, policy advocates, and community organizers working to protect biological rights in your state. Help us draft legislation, educate the public, and build coalitions.
Like the EFF, the BFF is funded by individuals who believe in protecting fundamental rights. Your support funds legal battles, policy research, and the technology tools that put biological sovereignty back in your hands.
Download our Biological Rights Toolkit — a comprehensive guide to your rights under GINA, HIPAA, state biometric laws, and emerging genetic privacy protections. Knowledge is the first line of defense.
Help build open-source tools for encrypted genetic data storage, health record sovereignty platforms, and biometric opt-out technologies. Your code can protect millions.
Subscribe to the BFF newsletter for updates on biological rights cases, policy developments, and action alerts. Follow us on social media and share the movement.
Essential reading for understanding the landscape of biological civil liberties.